Home Cart 0 Sign in  

[ CAS No. 62-57-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 62-57-7
Chemical Structure| 62-57-7
Structure of 62-57-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62-57-7 ]

Related Doc. of [ 62-57-7 ]

Alternatived Products of [ 62-57-7 ]

Product Details of [ 62-57-7 ]

CAS No. :62-57-7 MDL No. :MFCD00008049
Formula : C4H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :FUOOLUPWFVMBKG-UHFFFAOYSA-N
M.W : 103.12 Pubchem ID :6119
Synonyms :
α-Aminoisobutanoic acid;H-Aib-OH;2-Methylalanine;α,α-Dimethylglycine;NSC 16590

Calculated chemistry of [ 62-57-7 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 25.86
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.92 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.7
Log Po/w (XLOGP3) : -2.81
Log Po/w (WLOGP) : -0.19
Log Po/w (MLOGP) : -2.61
Log Po/w (SILICOS-IT) : -0.89
Consensus Log Po/w : -1.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 1.36
Solubility : 2350.0 mg/ml ; 22.7 mol/l
Class : Highly soluble
Log S (Ali) : 2.04
Solubility : 11200.0 mg/ml ; 108.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 0.36
Solubility : 234.0 mg/ml ; 2.27 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 62-57-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62-57-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62-57-7 ]
  • Downstream synthetic route of [ 62-57-7 ]

[ 62-57-7 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 62-57-7 ]
  • [ 615-36-1 ]
  • [ 80636-30-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2010, vol. 352, # 14-15, p. 2531 - 2537
[2] Research on Chemical Intermediates, 2014, vol. 40, # 6, p. 2157 - 2164
[3] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4119 - 4121
  • 2
  • [ 62-57-7 ]
  • [ 124-68-5 ]
Reference: [1] Monatshefte fuer Chemie, 1953, vol. 84, p. 1097
[2] Chimica Therapeutica, 1969, vol. 4, p. 80 - 88
[3] European Journal of Organic Chemistry, 2008, # 2, p. 350 - 355
[4] Synlett, 2008, # 12, p. 1829 - 1832
  • 3
  • [ 19355-69-2 ]
  • [ 16252-90-7 ]
  • [ 13027-88-8 ]
  • [ 62-57-7 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1984, vol. 20, p. 1243 - 1247[2] Zhurnal Organicheskoi Khimii, 1984, vol. 20, # 7, p. 1367 - 1371
[3] Journal of Organic Chemistry USSR (English Translation), 1984, vol. 20, p. 1243 - 1247[4] Zhurnal Organicheskoi Khimii, 1984, vol. 20, # 7, p. 1367 - 1371
  • 4
  • [ 62-57-7 ]
  • [ 2052-01-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 17, p. 2037 - 2039
  • 5
  • [ 24424-99-5 ]
  • [ 62-57-7 ]
  • [ 30992-29-1 ]
YieldReaction ConditionsOperation in experiment
80% With sodium hydroxide In 1,4-dioxane at 20℃; for 16 h; Preparational Example 26
Preparation of 2-(t-butoxycarbonylamino)-2-methylpropanoic acid
200 mg (1.94 mmol) of 2-amino-2-methylpropanoic acid was dissolved in 8.0 ml of 1.0 N NaOH solution and 8.0 ml of 1,4-dioxane solution, to which 846 mg (3.88 mmol) of Boc2O was added.
The mixture was stirred at room temperature for 16 hours, and then 1,4-dioxane was eliminated by evaporation under reduced pressure.
The residue was acidized with 1 N HCl to be pH 3, and followed by extraction with 320 ml of ethyl acetate.
The extract was dried over anhydrous magnesium sulfate, followed by evaporation under reduced pressure to give 315 mg of 2-(t-butoxycarbonylamino)-2-methylpropanoic acid (yield: 80percent).
1H NMR (400 MHz, CDCl3) δ 5.07 (brs, 1H), 1.54 (s, 6H), 1.45 (s, 9H)
80% With sodium hydroxide In 1,4-dioxane at 20℃; for 16 h; 200 mg (1.94 mmol) of 2-amino-2-methylpropanoic acid was dissolved in 8.0 ml of 1.0 N NaOH solution and 8.0 ml of 1,4-dioxane solution, to which 846 mg (3.88 mmol) of Boc2O was added. The mixture was stirred at room temperature for 16 hours, and then 1,4-dioxane was eliminated by evaporation under reduced pressure. The residue was acidized with 1 N HCl to be pH 3, and followed by extraction with 320 ml of ethyl acetate. The extract was dried over anhydrous magnesium sulfate, followed by evaporation under reduced pressure to give 315 mg of 2-(t-butoxycarbonylamino)-2-methylpropanoic acid (yield: 80percent). 1H NMR (400 MHz, CDCl3) δ 5.07 (brs, 1H), 1.54 (s, 6H), 1.45 (s, 9H)
67% With sodium hydroxide; water In 1,4-dioxane at 20℃; for 15 h; α-Aminoisobutyric acid (1.0 g, 9.70 mmol) was dissolved in a mixture of dioxane (15.0 mL) and 0.5 M NaOH (15.0 mL).
To this solution was added di-tert-butyl dicarbonate (2.5 g, 11.64 mmol, 1.2 equiv.) and the resulting mixture stirred at RT for 15 h.
The reaction mixture was concentrated under reduced pressure and diluted with EtOAc (50 mL) and 1 M HCl (30 mL).
The aqueous solution was extracted with EtOAc (2*30 mL) and the combined organic phases were washed with brine (40 mL), dried over sodium sulfate, and concentrated under reduced pressure to afford the title compound (1.3 g, 67percent) as a white solid: mp 122-123° C.; 1H NMR (CDCl3+methanol-d4) δ 1.44 (s, 9H), 1.51 (s, 6H), 3.99 (br s, NH).
66% With sodium hydroxide In 1,4-dioxane at 0 - 20℃; To a stirred solution of 2-Amino-2-methylpropanoic acid (50 g, 484.87 mmol, 1.0 eq)in 1,4-dioxane (500 mL) at 0 oc was added 2N NaOH solution (500 mL) followed by di-tertbutyldicarbonate(158.55 g, 727.30 mmol, 1.5 eq). The reaction mixture was allowed to stir atroom temperature for overnight. After completion of the reaction (monitored by TLC), the organic phase was evaporated under reduced pressure, reaction mixture was diluted withwater (100 mL), cooled to 0 °C, pH adjusted to 5 with IN HCI and then extracted with DCM(3x500 mL). The combined organic extracts were washed with water (500 mL) and brinesolution (200 mL). The organic layer was dried over Na2S04, filtered and evaporated underreduced pressure. The residue was stirred with n-hexane (500 mL) at room temperature for about 30 minutes. The solid was filtered and dried under vacuum to obtain the title compound(65 g, yield: 66percent) as a white solid. 1H NMR (300 MHz, CDCh): 8 ppm 9.50 (brs, IH), 1.53(s, 6H), 1.44 (s, 9H); ESI-MS: m/z 226.03 (M+Nat
64.4% With sodium hydroxide In 1,4-dioxane; water at 20℃; Method 1 : To a stirred solution of 2-Amino-2-methylpropanoic acid (30 g, 290.92 mmol, 1.0 eq) in 1,4-dioxane (300 ml) at 0 °C was added 2N NaOH solution (300 ml) followed by (Boc)20 (95.13 g, 436.38 mmol, 1.5 eq). The reaction mixture was allowed to stir at room temperature for overnight. TLC indicated starting material was consumed and the desired product was observed. The organic phase was evaporated under reduced pressure, the reaction mixture was diluted with water (50 ml), cooled to 0 °C, pH adjusted to 5 with IN HC1 and then extracted with DCM (3x300 ml). The combined organic extracts were washed with water (300 ml), brine (100 ml) solution, dried over Na2S04, filtered and evaporated under reduced pressure. The residue was stirred with n-hexane (300 ml) at room temperature for about 30 minutes. The obtained solid was filtered and dried under vacuum to obtain the desired product (38.0 g, yield: 64.4percent) as a white solid.
61% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 16 h; Inert atmosphere A solution of compound 14 (10.0 grams, 97.0 mmol) in dioxane (150 ml) and NaOH (5percent, 150 ml) was cooled to 0° C., then Boc2O was added dropwised. The mixture was stirred for 16 hours at room temperature under N2 atmosphere, then added HCl (concentrated) to make PH to 3, and the mixture was extracted with EtOAc (100 ml×3), washed with brine (50 ml), dried over Na2SO4, concentrated in vacuo and purified on silica gel column (PE/EtOAc=5:1) to give the product as white solid (12.1 grams, 61percent yield).
49% With triethylamine In methanol at 60℃; for 0.5 h; The starting materials N1, 2-dimetliylalaninamide and 2-methylalaninamide used in Examples 95 and 97 were prepared from 2-aminoisobutyric acid (ex. Aldrich) following the procedure below: Di-tert-butlydicarbonate (6.98 g, 32.0 mmol) was added to a stirred solution of the 2- aminoisobutyric acid (3 g, 29.13 mmol) in methanol/triethylmine (10/90) (100 ml). The reaction mixture was heated at 60°C/30 minutes, cooled to room temperature and concentrated to dryness. The residue was taken up in dichloromethane (100 ml), washed with 10percent aqueous potassium hydrogensulfate, water, dried over magnesium sulfate, filtered and evaporated to dryness to give N-(tert-butoxycarbonyl)-2-methylalanine (2.87 g, 49percent) as a white solid ; 1H NMR Spectrum : (CDC13) 1.45 (s, 6H), 1.53 (s, 9H), 5.2 (br s, 1H).
45.44% With hydrogenchloride; sodium hydroxide In tetrahydrofuran E.
2-tert-Butoxycarbonylamino-2-methyl-propionic acid
2-Aminoisobutyric acid (140 g, 1.36 mol), 1 N NaOH (1620 mL, 1.63 mol), (Boc)2O (375 mL, 1.63 mol) and THF 420 mL were mixed together and stirred at room temperature overnight.
The reaction mixture was diluted with ethyl acetate (700 mL) and adjusted to about pH 3.0 by adding 6 N HCl.
The organic phase separated was washed with saturated NaCl solution and concentrated to approximately 1/4 of the original volume.
After treatment with hexane a white solid product was isolated and collected (125.8 g, yield 45.44 percent).
An additional 7.8 g of product was recovered from the mother liquor.
44% With sodium hydroxide In tetrahydrofuran at 20℃; Step 1To a solution of 2-amino-2-methylpropanoic acid (10.3 g, 0.1 mol, 1.0 equiv) in 1 N NaOH (100 mL) and Tiff (30 mL) was added (Boc)20 (26 g, 0.12 rnol, 1.2 equiv) portionwise at room temperature. This mixture was stirred overnight at room temperature. The mixture was concentrated and then extracted with ethyl acetate (100 mLx2). The aqueous phase was adjusted to PH=3~4, then extracted with ethyl acetate (200 mLx2), The organic phases were combined, washed with brine, dried over Na2SC>4. concentrated to give 9 g (44percent) of the desired product 2-(tert-butoxycarbonylamino)-2-methylpropanoic acid as a white solid
44% With sodium hydroxide In tetrahydrofuran at 20℃; Step 1. To a solution of 2-amino-2-methylpropanoic acid (10.3 g, 0.1 mol, 1.0 equiv) in 1 N NaOH (100 mL) and THF (30 mL) was added (Boc)2O (26 g, 0.12 mol, 1.2 equiv) portionwise at room temperature. This mixture was stirred overnight at room temperature. The mixture was concentrated and then extracted with ethyl acetate (100 mLx2). The aqueous phase was adjusted to PH=3~4, then extracted with ethyl acetate (200 mLx2). The organic phases were combined, washed with brine, dried over Na2SO4, concentrated to give 9 g (44percent)of the desired product 2-(tert-butoxycarbonylamino)-2-methylpropanoic acid as a white solid.
40.7% With sodium hydroxide In tetrahydrofuran; water at 20℃; To a solution of 2-amino-2-methylpropanoic acid (4.0 g, 39 mmol) , NaOH (1.55 g, 38.8 mmol) , water (50 mL) , and THF (20 mL) was added (Boc)2O (10.16 g, 46.55 mmol) portion wise at rt. The mixture was stirred overnight at rt, then concentrated to dryness, and extracted with EtOAc. The pH of the aqueous layer was adjusted to 3-4 with 1 M aqueous HCl, extracted with EtOAc, washed with brine, dried over anhydrous Na2SO4, and concentrated to dryness to give the title compound as a white solid (3.21 g, 40.7yield) .

Reference: [1] Bulletin of the Chemical Society of Japan, 1987, vol. 60, # 4, p. 1391 - 1397
[2] Angewandte Chemie - International Edition, 2018, vol. 57, # 20, p. 5679 - 5683[3] Angew. Chem., 2018, vol. 130, p. 5781 - 5785,5
[4] Patent: US2015/210635, 2015, A1, . Location in patent: Paragraph 0502-0504
[5] Patent: EP2865664, 2015, A1, . Location in patent: Paragraph 0118; 0119
[6] Journal of Molecular Structure, 2003, vol. 646, # 1-3, p. 111 - 123
[7] Chemistry - A European Journal, 2012, vol. 18, # 31, p. 9516 - 9520
[8] Patent: US7202279, 2007, B1, . Location in patent: Page/Page column 49
[9] Patent: WO2018/29604, 2018, A1, . Location in patent: Page/Page column 28; 29
[10] Patent: WO2016/178092, 2016, A2, . Location in patent: Page/Page column 39
[11] Tetrahedron, 2004, vol. 60, # 40, p. 8929 - 8936
[12] Patent: US9096645, 2015, B2, . Location in patent: Page/Page column 39; 40
[13] Polish Journal of Chemistry, 1991, vol. 65, # 7-8, p. 1427 - 1431
[14] Tetrahedron Letters, 1996, vol. 37, # 40, p. 7319 - 7322
[15] Patent: WO2005/75439, 2005, A1, . Location in patent: Page/Page column 198-199
[16] Patent: US6448263, 2002, B1,
[17] Patent: WO2012/158764, 2012, A1, . Location in patent: Page/Page column 229
[18] Patent: WO2014/22569, 2014, A1, . Location in patent: Page/Page column 108; 109
[19] Patent: WO2018/103058, 2018, A1, . Location in patent: Page/Page column 349
[20] Patent: WO2005/19174, 2005, A1, . Location in patent: Page/Page column 51-52
[21] Patent: US2012/322811, 2012, A1, . Location in patent: Page/Page column 18
[22] Patent: WO2017/100668, 2017, A1, . Location in patent: Page/Page column 349
  • 6
  • [ 62-57-7 ]
  • [ 142842-93-1 ]
  • [ 30992-29-1 ]
YieldReaction ConditionsOperation in experiment
44% With sodium hydroxide In tetrahydrofuran at 20℃; Step 1To a solution of 2-amino-2-methylpropanoic acid (10.30.1 mol, 1.0 equiv) in 1 N NaOH (100 mE) and THF (30 mE) was added (l3oc)20 (26 g, 0.12 mol, 1.2 equiv) portionwiseroom temperature. This mixture was stirred overnight at room temperature. The mixture was concentrated and then extracted with ethyl acetate (100 mEx2). The aqueous phase was adjusted to PH=34, then extracted with ethyl acetate (200 mEx2). The organic phases were combined, washed with brine, dried over Na2504, concentrated to give 9 g (44percent) of the desired product 2-(tert-butoxycarbonylamino)-2-me- thylpropanoic acid as a white solid.
Reference: [1] Patent: US8673925, 2014, B1, . Location in patent: Page/Page column 253
  • 7
  • [ 58632-95-4 ]
  • [ 62-57-7 ]
  • [ 30992-29-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 19, p. 5133 - 5140
[2] Journal of the American Chemical Society, 1981, vol. 103, # 20, p. 6127 - 6132
  • 8
  • [ 123-91-1 ]
  • [ 24424-99-5 ]
  • [ 62-57-7 ]
  • [ 30992-29-1 ]
Reference: [1] Patent: US5332734, 1994, A,
  • 9
  • [ 18595-34-1 ]
  • [ 62-57-7 ]
  • [ 30992-29-1 ]
Reference: [1] Tetrahedron, 1991, vol. 47, # 2, p. 259 - 270
  • 10
  • [ 1070-19-5 ]
  • [ 62-57-7 ]
  • [ 30992-29-1 ]
Reference: [1] Tetrahedron, 1982, vol. 38, # 14, p. 2165 - 2182
[2] Journal of medicinal chemistry, 1971, vol. 14, # 10, p. 904 - 906
  • 11
  • [ 62-57-7 ]
  • [ 501-53-1 ]
  • [ 15030-72-5 ]
YieldReaction ConditionsOperation in experiment
97% With sodium carbonate In 1,4-dioxane; water at 0 - 20℃; for 18 h; Preparation 56 N-[(Benzyloxy)carbonyl1-2-methylalanine To a solution of 2-methylalanine (50 g, 0.49 mmol) and Na2CO3 (156 g, 1 .47 mol) in water (1 L) was added a solution of CbzCI (91 g, 0.54 mmol) in dioxane (500 mL) at 0°C over 15 minutes. The resulting solution was stirred at room temperature for 18 hours. The reaction was extracted with Et2O (2 x 500 mL), and the aqueous layer collected, acidified to pH=1 with cHCI and extracted with EtOAc (2 x 500 mL). The organic layers were combined, washed with brine, dried over Na2SO4 and concentrated in vacuo to afford a white solid as the title compound that was used directly in the next step (1 1 1 g, 97percent).
72% With sodium carbonate In 1,4-dioxane; water at 23℃; for 24 h; A mixture containing sodium carbonate (3 equiv.), 2-amino-2-methylpropanoic acid (1.0 equiv.) and benzyl chloroformate (1.1 equiv.) in water and 1 ,4-dioxane (2:1) was stirred at 23 °C for 24 h. The mixture was diluted in ethyl acetate and washed with IN HC1 solution. The organic layer was dried, filtered and evaporated to deliver the desired intermediate 2-(((benzyloxy)carbonyl)amino)-2-methylpropanoic acid (825 mg, 72percent yield) as a clear oil. 'H NMR (500 MHz, CD3OD) δ ppm 7.32 - 7.38 (m, 5 H), 5.03 - 5.09 (m, 2 H), 1.43 - 1.50 (m, 6 H).
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 2, p. 533 - 548
[2] Patent: WO2013/114250, 2013, A1, . Location in patent: Page/Page column 163
[3] Helvetica Chimica Acta, 2011, vol. 94, # 6, p. 993 - 1011
[4] Tetrahedron, 1982, vol. 38, # 14, p. 2165 - 2182
[5] Helvetica Chimica Acta, 1988, vol. 71, p. 140 - 154
[6] Patent: WO2016/44447, 2016, A1, . Location in patent: Paragraph 00326
[7] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 2001, vol. 40, # 1, p. 70 - 74
[8] Helvetica Chimica Acta, 1987, vol. 70, p. 102 - 115
[9] Tetrahedron, 1960, vol. 11, p. 39 - 51
[10] Tetrahedron, 1967, vol. 23, # 5, p. 2017 - 2030
[11] Bulletin of the Chemical Society of Japan, 1970, vol. 43, # 11, p. 3457 - 3461
[12] Journal fuer Praktische Chemie (Leipzig), 1960, vol. 11, p. 153 - 164
[13] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 9, p. 2448 - 2451
[14] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 17, p. 8054 - 8062
[15] European Journal of Medicinal Chemistry, 2012, vol. 50, p. 361 - 369
[16] Patent: US2012/316147, 2012, A1, . Location in patent: Page/Page column 30
[17] Patent: WO2012/168350, 2012, A1, . Location in patent: Page/Page column 73; 74
[18] Patent: WO2010/95768, 2010, A1, . Location in patent: Page/Page column 40-42
  • 12
  • [ 13139-17-8 ]
  • [ 62-57-7 ]
  • [ 15030-72-5 ]
YieldReaction ConditionsOperation in experiment
97.8% With sodium carbonate In tetrahydrofuran; water at 20℃; for 16 h; Step 1.
Cbz-OSu (57 g, 0.23 mol) in THF (150 mL) was added a mixture of aq Na2C03 (82 g, 0.78 mol) and 80-1 (20 g, 0.19 mol). After it was stirred at r.t. for 16 h, it was adjusted to pH > 10 and washed with EtOAc (400 mL x 2). The aqueous layer was pooled and acidified to pH < 1 with cone. HC1. It was extracted with EtOAc (500 mL x 2). The organic layer was dried over Na2S04 and evaporated to give 80-2 (45 g, 97.8percent).
72%
Stage #1: With sodium hydrogencarbonate In tetrahydrofuran; water at 0 - 20℃; for 12 h;
Stage #2: at 0℃;
Synthesis of Compound S.2. To S.1 (10 g, 0.0969 mol) in THF (60 ml) and water (60 mL) at 0° C. was added sodium bicarbonate (16.27 g, 0.193 mole) followed by N-(benzyloxy carbonyloxy) succinimide (60.37 g, 0.242 mol). The reaction mixture was stirred at RT for 12 hr. The THF was removed under vacuum and the aqueous phase was washed with ether (2.x.100 mL). The aqueous phase was cooled to 0° C. and acidified to pH=2 with 5N HCL (50 mL). The reaction mixture was extracted with ethyl acetate (2.x.100 mL); the combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The crude material was purified by column chromatography (1percent MeOH in dichloromethane) to give S.2 (16 g, 72percent). 1H NMR (CDCl3, 200 MHz) δ 7.45-7.32 (m, 5H), 5.40 (bs, 1H,) 5.12 (s, 2H), 1.82 (s, 6H); MS: m/z 238 [M+1]+.
72%
Stage #1: With sodium hydrogencarbonate In tetrahydrofuran; water at 0 - 20℃; for 12 h;
Stage #2: With hydrogenchloride In water
To S.1 (10 g, 0.0969 mol) in THF (60 ml) and water (60 mL) at 0° C. was added sodium bicarbonate (16.27 g, 0.193 mole) followed by N-(benzyloxy carbonyloxy) succinimide (60.37 g, 0.242 mol). The reaction mixture was stirred at RT for 12 hr. The THF was removed under vacuum and the aqueous phase was washed with ether (2.x.100 mL). The aqueous phase was cooled to 0° C. and acidified to pH=2 with 5N HCL (50 mL). The reaction mixture was extracted with ethyl acetate (2.x.100 mL); the combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The crude material was purified by column chromatography (1percent MeOH in dichloromethane) to give S.2 (16 g, 72percent). 1H NMR (CDCl3, 200 MHz) δ 7.45-7.32 (m, 5H), 5.40 (bs, 1H,) 5.12 (s, 2H), 1.82 (s, 6H); LCMS: m/z 238 [M+1]+.
Reference: [1] Patent: WO2015/95227, 2015, A2, . Location in patent: Page/Page column 215
[2] Patent: US2009/5359, 2009, A1, . Location in patent: Page/Page column 48-49
[3] Patent: US2009/36419, 2009, A1, . Location in patent: Page/Page column 93
[4] Chemical Communications, 2013, vol. 49, # 86, p. 10133 - 10135
[5] Journal of Organic Chemistry, 2004, vol. 69, # 11, p. 3849 - 3856
  • 13
  • [ 62-57-7 ]
  • [ 15030-72-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1970, vol. 43, p. 3873,3881
  • 14
  • [ 62-57-7 ]
  • [ 501-53-1 ]
  • [ 15030-72-5 ]
  • [ 79775-03-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1986, p. 1371 - 1376
[2] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1986, p. 1371 - 1376
  • 15
  • [ 67-56-1 ]
  • [ 62-57-7 ]
  • [ 15028-41-8 ]
YieldReaction ConditionsOperation in experiment
98% at 20℃; for 3 h; Cooling with ice 2-amino-2-methylpropionic acid (10 g, 96.9 mmol) and methanol (330 ml) were charged. An ice bath was set and thionyl chloride (17.68 ml, 242.25 mmol) was slowly added thereto. Then, the ice bath was removed, and the mixture was stirred at room temperature for 3 hours. The resultant product was vacuum-distilled to remove a solvent, and dried in a 60 oven so as to obtain methyl-2-amino-2-methylpropanoate hydrochloride (14.59 g, 94.9 mmol, 98 percent).[938] 1H NMR (400 MHz, DMSO-d6) 8.75 (br, 3H), 3.75 (s, 3H), 1.45 (s, 6H).
98% at 20℃; for 3 h; Cooling with ice 2-amino-2-methylpropionic acid (10 g, 96.9 mmol) and methanol (330 ml) were charged. An ice bath was set and thionyl chloride (17.68 ml, 242.25 mmol) was slowly added thereto. Then, the ice bath was removed, and the mixture was stirred at room temperature for 3 hours. The resultant product was vacuum-distilled to remove a solvent, and dried in a 60° C. oven so as to obtain methyl-2-amino-2-methylpropanoate hydrochloride (14.59 g, 94.9 mmol, 98percent). [0514] 1H NMR (400 MHz, DMSO-d6) 8.75 (br, 3H), 3.75 (s, 3H), 1.45 (s, 6H).
80% for 12 h; Reflux To a suspension of 2-aminoisobutyric acid (25.0 g, 243 mmol) in methanol (300 ml.) was added thionyl chloride (27.0 ml_, 43.0 g, 365 mmol) and the reaction was heated at reflux for 12 hours. The resulting solution was concentrated and triturated with diethyl ether - tetrahydrofuran to yield the product as a white powder, 29.8 g (80 percent).1H NMR (DMSO-d6, 300 MHz): δ 8.80 (broad s, 3H, NH3+), 3.74 (s, 3H, CH3O), 1.48 (s, 6H, 2 x CH3).
79% at 0 - 60℃; for 26.25 h; Aminoisobutyric acid (29.80 g, 0.2890 mol) was suspended in MeOH (300 mE) and the suspension cooled to 0°C. (ice bath). Thionyl chloride (36.10 g, 0.3034 mol) was added dropwise over 15 mm. The ice bath was removed and the reaction mixture stirred at 60°C. for 4 h. The oil bath was then removed and stirring continued at room temperature for another 22 h. The solvent and excess thionyl chloride were evaporated affording a white solid with a strong sulfur smell. Methanol (5x 150 mE) was added and evaporated. The residue was dissolved in MeOH (120 mE), precipitated by addition of Et20 (720 mE) and collected by filtration under suction affording the title compound as a white solid (35.12 g, 79percent), with spectral characteristics in accordance with literature data’; ‘H NMR (200 MHz, DMSO-d5) ö 8.87 (br s, 3H, NH3), 3.72 (s, 3H, OCH3), 1.48 (s, 6H, CH3); ‘3CNMR(75 MHz, DMSO-d5) ö 172.0,55.8, 53.1, 23.3; HRMS (mlz): M calcd. for C5,H,2N02, 118.0868. found, 118.0871; Anal. Calcd. for C5H,2C1N02: C, 39.10; H, 7.87; N, 9.12. Found:C, 38.9; H, 7.8; N, 9.0.

Reference: [1] Organic Letters, 2012, vol. 14, # 18, p. 4798 - 4801
[2] European Journal of Organic Chemistry, 2004, # 20, p. 4167 - 4176
[3] Patent: WO2013/19091, 2013, A2, . Location in patent: Paragraph 936-938
[4] Patent: US2014/206875, 2014, A1, . Location in patent: Paragraph 0513-0514; 0568-0569; 0599-0600; 0658-0660
[5] Tetrahedron, 1982, vol. 38, # 14, p. 2165 - 2182
[6] Journal of Organic Chemistry, 2014, vol. 79, # 21, p. 10132 - 10142
[7] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2006, vol. 45, # 8, p. 1942 - 1944
[8] Journal of Labelled Compounds and Radiopharmaceuticals, 2000, vol. 43, # 10, p. 1013 - 1021
[9] Journal of Organic Chemistry, 1982, vol. 47, # 15, p. 2982 - 2987
[10] Tetrahedron, 2007, vol. 63, # 36, p. 8855 - 8871
[11] Patent: WO2010/70318, 2010, A1, . Location in patent: Page/Page column 21
[12] Journal of Organic Chemistry, 2011, vol. 76, # 5, p. 1228 - 1238
[13] Patent: US9227995, 2016, B2, . Location in patent: Page/Page column 37
[14] Journal of Medicinal Chemistry, 1984, vol. 27, # 12, p. 1663 - 1668
[15] Recueil des Travaux Chimiques des Pays-Bas, 1908, vol. 27, p. 204
[16] Heterocycles, 1991, vol. 32, # 10, p. 1879 - 1895
[17] Collection of Czechoslovak Chemical Communications, 1996, vol. 61, # 6, p. 910 - 920
[18] Journal of Medicinal Chemistry, 2006, vol. 49, # 24, p. 7215 - 7226
[19] Chemistry - A European Journal, 2000, vol. 6, # 24, p. 4498 - 4504
[20] Organic Letters, 2007, vol. 9, # 25, p. 5275 - 5278
[21] Synlett, 2009, # 8, p. 1227 - 1232
[22] Patent: US6353006, 2002, B1, . Location in patent: Page column 138
[23] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 12, p. 3502 - 3506
[24] Patent: WO2011/69951, 2011, A1, . Location in patent: Page/Page column 82
[25] Acta Crystallographica Section C: Crystal Structure Communications, 2011, vol. 67, # 8, p. o283-o287
[26] Journal of the American Chemical Society, 2014, vol. 136, # 51, p. 17818 - 17826
[27] Molecules, 2015, vol. 20, # 2, p. 1755 - 1774
[28] Physical Chemistry Chemical Physics, 2016, vol. 18, # 36, p. 25512 - 25527
  • 16
  • [ 62-57-7 ]
  • [ 15028-41-8 ]
Reference: [1] Chemical Communications, 2012, vol. 48, # 49, p. 6181 - 6183
[2] Patent: US2002/19539, 2002, A1,
[3] Patent: US5475013, 1995, A,
[4] Patent: US3966796, 1976, A,
  • 17
  • [ 62-57-7 ]
  • [ 74-88-4 ]
  • [ 15028-41-8 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2004, vol. 77, # 6, p. 1187 - 1193
  • 18
  • [ 67-56-1 ]
  • [ 75-77-4 ]
  • [ 62-57-7 ]
  • [ 15028-41-8 ]
Reference: [1] Tetrahedron, 1991, vol. 47, # 47, p. 9807 - 9822
  • 19
  • [ 62-57-7 ]
  • [ 17288-15-2 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 0 - 20℃; for 1 h;
Stage #2: Heating / reflux
(B) General Procedure for Preparing amino acid ester hydrochloric Salts Thionyl chloride (2.0 mol. equivalents) was added dropwise to a stirred solution of the appropriate anhydrous alcohol (10.0 mol equivalents) under argon atmosphere and cooled to 0° C. The mixture was stirred at 0° C. for 1 h and then slowly allowed to warm to RT. The appropriate amino acid (1.0 mol. equivalents) was added and the mixture was heated at reflux overnight. The solvent was removed under reduced pressure (last traces of solvent were removed by co-evaporation with increasingly more volatile solvents). The crude product was then triturated with Et2O to afford the pure amino acid ester hydrochloric salt. EXAMPLE 14 2-[(2R,3S,4R,5R)-5-(4-Amino-2-oxo-2H-pyrimidin- 1-yl)-2-azido-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-2-methyl-propionic acid ethyl ester (I-10) and 2-[(2R,3S,5R)-5-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]-hydroxy-phosphorylamino}-2-methyl-propionic acid; compound with ammonia (I-69) step 1-Ethyl 2-amino-2-methylpropanoate hydrochloride salt The title compound was prepared according to Example 1 (A) utilizing 2-amino-isobutyric acid (8.0 g, 77.6 mmol), thionyl chloride (11.3 mL, 155.2 mmol) and anhydrous EtOH (45.5 mL, 776.0 mmol). The product 14n was isolated as a white solid (9.12 g, yield 70percent). 1H-NMR (CDCl3; 300 MHz): δ 8.93 (3H, bs, NH3Cl), 4.25 (2H, q, J=7.1 Hz, OCH2CH3), 1.72 (6H, s, [CH3]2C), 1.30 (3H, t, J=7.1 Hz, OCH2CH3); 13C-NMR (CDCl3; 75 MHz): δ 14.4 (OCH2CH3), 24.3 ([CH3]2C), 57.8 (C[CH3]2), 63.0 (OCH2CH3), 171.5 (CO).
Reference: [1] Patent: US2007/42988, 2007, A1, . Location in patent: Page/Page column 18; 22
[2] Patent: US6028032, 2000, A,
  • 20
  • [ 64-17-5 ]
  • [ 62-57-7 ]
  • [ 17288-15-2 ]
Reference: [1] Australian Journal of Chemistry, 1999, vol. 52, # 5, p. 379 - 385
[2] Tetrahedron Letters, 2007, vol. 48, # 34, p. 5973 - 5975
[3] ChemBioChem, 2017, vol. 18, # 3, p. 300 - 315
[4] Canadian Journal of Chemistry, 1992, vol. 70, # 5, p. 1328 - 1337
[5] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 19, p. 2699 - 2711
[6] Journal of the American Chemical Society, 1924, vol. 46, p. 412
[7] Patent: WO2012/52781, 2012, A1, . Location in patent: Page/Page column 23-24; 30-31
[8] Patent: US2013/211083, 2013, A1, . Location in patent: Paragraph 0094; 0095
  • 21
  • [ 28920-43-6 ]
  • [ 62-57-7 ]
  • [ 94744-50-0 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 2001, vol. 40, # 1, p. 70 - 74
  • 22
  • [ 749927-69-3 ]
  • [ 62-57-7 ]
  • [ 1289942-66-0 ]
YieldReaction ConditionsOperation in experiment
87% With water; potassium carbonate; <i>L</i>-proline; copper(l) chloride In N,N-dimethyl-formamide at 100℃; for 24 h; Inert atmosphere 4-bromo-2-fluoro -N- methylbenzamide, 2-amino - isobutyric acid molar ratio, catalyst, co-catalyst, acid binding agent, followed by water 1:1.5:0.1:0.1:4:2.3
In a single-neck flask was added4-bromo-2-fluoro -N- methylbenzamide (10g, 43.1mmol), 2- amino - isobutyric acid (6.7g, 64.7mmol), potassium carbonate (23.8g, 172.4mmol), proline (0.7g, 4.31mmol), water (1.8ml, 100mmol) was dissolved in DMF (60ml), andStirring under nitrogen replacementAfter addition of CuCl (0.45g, 4.31mmol), was heated to 100 , reaction 24h.After completion of the reaction first added water (120ml) the mixture was diluted, added and extracted with dichloromethane, the organic phase was removed, the aqueous phase was adjusted pH = 4 with 1mol / L citric acid solution, and the precipitated solid was filtered. The solid washed with water and ethanol (100: 1) mixed solution was washed three times to give pure white solid 9.5g. Yield 87percent
75.4%
Stage #1: With potassium carbonate In water; N,N-dimethyl-formamide at 30℃;
Stage #2: With 2-acetylcyclohexanone In water; N,N-dimethyl-formamide at 105℃; Inert atmosphere
Stage #3: With citric acid In Isopropyl acetate; water
The bromobenzamide A-2 (10 g, 43.1 mmol), aminoisobutyric acid B-l (6.7 g, 64.6 mmol, 1.5 equiv), K2C03 (15 g, 2.5 equiv), 99percent CuCl (0.8 g, 8.1 mmol, 0.2 equiv), DMF (60 mL, 6 vol) and water (1.8 mL) were added to the flask and the reaction slurry was heated to 30 °C. 2-Acetylcyclohexanone (1.14 mL, 8.1 mmol, 0.2 equiv) was added to the reaction slurry followed by stirring at 105 °C under nitrogen for 12-14 h. HPLC analysis showed 96.6percent conversion to the desired product. The reaction mixture was then cooled to RT and extracted with water (120 mL) and IP Ac (60 mL). The lower aqueous layer was re-extracted with IP Ac (60 mL) and acidified with 180 mL of 1M citric acid to a pH of 4.0. The product began to crystallize at RT and the batch was further cooled to 5-7 °C, filtered, washed with water (40 mL) and dried under vacuum at 50 °C for 12 h. The reaction yielded 8.3 g of product C-1 (75.4percent yield) as a tan solid with HPLC purity of 99.6percent.
26 g
Stage #1: With potassium carbonate In 1,4-dioxane; water; N,N-dimethyl-formamide for 0.333333 h; Inert atmosphere
Stage #2: With <i>L</i>-proline; copper(l) chloride In 1,4-dioxane; water; N,N-dimethyl-formamide for 24.33 h; Inert atmosphere; Reflux
4-bromo-2-fluoro-N-methyl benzamide (48.0 gm, 0.21mol) and K2C03 (52.8 gm, 0.38 mol) was charged in to reaction flask containing DMF (67.2 mL), 1,4-dioxane (268mL) and DM water (8.6mL). The reaction mixture was purged with nitrogen gas for 20 min and then charged CuCl (6.24 gm, 0.06 mol),L-proline(9.6 gm, 0.08 mol) and 2-aminoisobutyric acid (31.6 gm, 0.31mol). Continue purging nitrogen gas for 20 min followed by refluxed for 24 hrs. Solvent is distilled off completely from the obtained reaction mixture under vacuum at 70°C. The reaction mass was cooled to 10 to 15 °C and then charged DM water (20 mL). The pH of the reaction mass adjusted to 3-5 with 1 M citric acid solution to obtain the title product. Yield: 26.0 gm Chromatographic Purity (By HPLC): 95.38 percent
Reference: [1] Patent: CN105330560, 2016, A, . Location in patent: Paragraph 0023; 0024; 0025; 0026; 0027
[2] Patent: WO2011/106570, 2011, A1, . Location in patent: Page/Page column 44
[3] Patent: WO2016/5875, 2016, A1, . Location in patent: Page/Page column 15
[4] Patent: CN104016924, 2016, B, . Location in patent: Paragraph 0017; 0026-0028
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 62-57-7 ]

Enzalutamide Related Intermediates

Chemical Structure| 749927-69-3

[ 749927-69-3 ]

4-Bromo-2-fluoro-N-methylbenzamide

Similar Product of
[ 62-57-7 ]

Chemical Structure| 5938-34-1

A1198085[ 5938-34-1 ]

2-Amino-2-methylpropanoic acid hydrochloride

Reason: Free-salt

Related Functional Groups of
[ 62-57-7 ]

Amino Acid Derivatives

Chemical Structure| 338-69-2

[ 338-69-2 ]

H-D-Ala-OH

Similarity: 0.84

Chemical Structure| 302-72-7

[ 302-72-7 ]

DL-Alanine

Similarity: 0.84

Chemical Structure| 56-41-7

[ 56-41-7 ]

H-Ala-OH

Similarity: 0.84

Chemical Structure| 6003-05-0

[ 6003-05-0 ]

(S)-2-Aminopropanoic acid hydrochloride

Similarity: 0.81

Chemical Structure| 595-40-4

[ 595-40-4 ]

(S)-2-Amino-2-methylbutanoic acid

Similarity: 0.81